About
Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing; offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain management drugs, and other generic and speciality products; and analgesics, skin care, vitamin and mineral supplement, kids' wellness, digestives, and women's health, as well as geriatric care. In addition, the company operates as a contract development and manufacturing organization, providing process development, scale-up, and GMP manufacturing services for vaccines and biologics. The company was incorporated in 2020 and is based in Mumbai, India.
Key Metrics
as of Sep 2026Market Cap28,525 Cr
P/E—
Div Yield0.07 %
Book Value₹61.40
52w High₹220.00
52w Low₹132.00
Face Value₹10.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,125.00 | 1,489.00 | 1,196.00 | 1,127.00 | 970.00 | 1,690.00 | 1,248.00 | 1,284.00 | 1,063.00 | 1,525.00 | 1,024.00 | 994.00 | 846.00 |
| Expenses | 1,008.00 | 1,186.00 | 1,029.00 | 1,000.00 | 926.00 | 1,273.00 | 1,029.00 | 1,032.00 | 912.00 | 1,136.00 | 899.00 | 908.00 | 830.00 |
| Operating Profit | 117.00 | 303.00 | 167.00 | 127.00 | 44.00 | 417.00 | 219.00 | 253.00 | 152.00 | 390.00 | 126.00 | 86.00 | 17.00 |
| OPM % | 10.00 | 20.00 | 14.00 | 11.00 | 4.60 | 25.00 | 18.00 | 20.00 | 14.00 | 26.00 | 12.00 | 9.00 | 2.00 |
| Other Income | 115.00 | 118.00 | 69.00 | 202.00 | 181.00 | 40.00 | 25.00 | 106.00 | 37.00 | 53.00 | 33.00 | 89.00 | 27.00 |
| Depreciation | 66.00 | 70.00 | 65.00 | 61.00 | 59.00 | 61.00 | 55.00 | 54.00 | 52.00 | 52.00 | 52.00 | 51.00 | 50.00 |
| Interest | 16.00 | 20.00 | 17.00 | 20.00 | 23.00 | 31.00 | 29.00 | 30.00 | 25.00 | 28.00 | 17.00 | 28.00 | 34.00 |
| Profit before tax | 149.00 | 332.00 | 155.00 | 247.00 | 143.00 | 364.00 | 159.00 | 276.00 | 112.00 | 363.00 | 90.00 | 96.00 | -41.00 |
| Tax % | 24.00 | 21.00 | 17.00 | 21.00 | 21.00 | 24.00 | 25.00 | 24.00 | 24.00 | 25.00 | 17.00 | 20.00 | -18.00 |
| Net Profit | 113.00 | 262.00 | 129.00 | 196.00 | 113.00 | 277.00 | 119.00 | 210.00 | 85.00 | 273.00 | 74.00 | 77.00 | -33.00 |
| EPS in Rs | 0.85 | 1.97 | 0.97 | 1.48 | 0.85 | 2.09 | 0.90 | 1.58 | 0.64 | 2.06 | 0.56 | 0.58 | -0.25 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Sales | 4,782.00 | 5,286.00 | 4,390.00 | 3,443.00 | 3,340.00 | 2,939.00 |
| Expenses | 4,140.00 | 4,245.00 | 3,772.00 | 3,345.00 | 2,864.00 | 2,320.00 |
| Operating Profit | 642.00 | 1,040.00 | 618.00 | 98.00 | 476.00 | 619.00 |
| OPM % | 13.00 | 20.00 | 14.00 | 2.80 | 14.00 | 21.00 |
| Other Income | 570.00 | 207.00 | 202.00 | 334.00 | 209.00 | 216.00 |
| Interest | 80.00 | 115.00 | 107.00 | 116.00 | 57.00 | 5.00 |
| Depreciation | 256.00 | 222.00 | 205.00 | 192.00 | 165.00 | 144.00 |
| Profit before tax | 877.00 | 911.00 | 508.00 | 124.00 | 462.00 | 687.00 |
| Tax % | 20.00 | 24.00 | 23.00 | 44.00 | 20.00 | 17.00 |
| Net Profit | 700.00 | 691.00 | 391.00 | 70.00 | 368.00 | 572.00 |
| EPS in Rs | 5.27 | 5.22 | 2.96 | 0.53 | — | — |
| Dividend Payout % | 0.00 | 3.00 | 4.00 | 0.00 | 18.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Equity Capital | 1,327.00 | 1,324.00 | 1,323.00 | 1,193.00 | 1,186.00 | 995.00 |
| Reserves | 6,814.00 | 6,128.00 | 5,389.00 | 4,068.00 | 3,937.00 | 3,106.00 |
| Borrowings | 786.00 | 1,243.00 | 1,177.00 | 1,649.00 | 1,164.00 | 174.00 |
| Other Liabilities | 2,826.00 | 1,696.00 | 1,662.00 | 1,131.00 | 1,083.00 | 1,482.00 |
| Total Liabilities | 11,753.00 | 10,392.00 | 9,551.00 | 8,042.00 | 7,371.00 | 5,757.00 |
| Fixed Assets | 3,036.00 | 2,894.00 | 2,612.00 | 2,602.00 | 2,439.00 | 1,627.00 |
| CWIP | 221.00 | 327.00 | 533.00 | 417.00 | 405.00 | 121.00 |
| Investments | 3,580.00 | 3,105.00 | 1,708.00 | 1,747.00 | 1,630.00 | 1,592.00 |
| Other Assets | 4,917.00 | 4,065.00 | 4,697.00 | 3,277.00 | 2,897.00 | 2,417.00 |
| Total Assets | 11,753.00 | 10,392.00 | 9,551.00 | 8,042.00 | 7,371.00 | 5,757.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | 1,328.00 | 549.00 | 358.00 | 72.00 | 249.00 | 35.00 |
| Cash from Investing Activity | -318.00 | -552.00 | -635.00 | -435.00 | -1,165.00 | -4,383.00 |
| Cash from Financing Activity | -615.00 | -62.00 | 451.00 | 290.00 | 896.00 | 4,494.00 |
| Net Cash Flow | 395.00 | -65.00 | 175.00 | -73.00 | -19.00 | 146.00 |
| Free Cash Flow | 1,040.00 | 267.00 | 33.00 | -171.00 | 18.00 | -20.00 |
| CFO/OP % | 225.00 | 75.00 | 71.00 | 135.00 | 74.00 | 21.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Debtor Days | 107.00 | 115.00 | 111.00 | 96.00 | 108.00 | 104.00 |
| Inventory Days | 330.00 | 196.00 | 200.00 | 169.00 | 125.00 | 125.00 |
| Days Payable | 355.00 | 193.00 | 192.00 | 157.00 | 151.00 | 174.00 |
| Cash Conversion Cycle | 83.00 | 118.00 | 119.00 | 108.00 | 82.00 | 56.00 |
| Working Capital Days | 74.00 | 73.00 | 63.00 | 25.00 | 38.00 | 18.00 |
| ROCE % | 12.00 | 12.00 | 8.00 | 4.00 | 10.00 | — |
Corporate Actions
4 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Dividend | 16 Jul 2025 | 16 Jul 2025 | — | 0.14 | |
| Dividend | 12 Jul 2024 | 12 Jul 2024 | — | 0.11 | |
| Rights | 02 Aug 2023 | 02 Aug 2023 | 5:46 | — | |
| Other | 02 Aug 2023 | 02 Aug 2023 | — | — | Right Issue of Equity Shares |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update17 Jul from care
-
Rating update15 Oct 2025 from icra
-
Rating update18 Jul 2025 from care
-
Rating update6 Mar 2025 from care
-
Rating update22 Oct 2024 from icra
-
Rating update4 Jul 2024 from care